Open Access

Spontaneous splenic infarction associated with sumatriptan use

The Journal of Headache and Pain20067:291

DOI: 10.1007/s10194-006-0291-5

Received: 16 April 2006

Accepted: 18 May 2006

Published: 15 June 2006

Abstract

Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.

Key words

Triptan Spleen Infarction